Back

Optimal serum uric acid levels for hypertension:5-year cohort study

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Hypertension risk factors and life style Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Masanari Kuwabara

Jichi Medical University, Shimotsuke (Japan)

14 More presentations in this session

Presentation thumbnail
Blood pressure and LDL-cholesterol control in patients with primary hypertension is far from optimal: results from a large observational, multicentric, prospective study
Professor D. Vinereanu (Bucharest, RO)
Abstract
Presentation thumbnail
High density lipoprotein cholesterol (HDL-C) levels and endothelial glycocalyx integrity in treated hypertensive patients
Doctor H. Triantafyllidi (Athens, GR)
Abstract Slides
Presentation thumbnail
Clinical profile of patients initiating evolocumab in Spanish Cardiology Units: A RETrospective, Observational Study of Real-World Clinical Practice (RETOSS-Cardio)
Professor V. Barrios (Madrid, ES)
Abstract Slides
Presentation thumbnail
Triglycerides are related to left ventricular mass in hypertensive patients, independently of other cardiometabolic risk factors: The effect of gender
Slides
Presentation thumbnail
Elevated serum uric acid associated with hypertension in healthy individuals
Doctor C. Liu (Taipei, TW)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Hypertension risk factors and life style

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources